- Home
- FGI vs ADXN Comparison
FGI vs ADXN Comparison
Compare FGI & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGI
- ADXN
- Stock Information
- Founded
- FGI 1987
- ADXN 2002
- Country
- FGI United States
- ADXN Switzerland
- Employees
- FGI N/A
- ADXN N/A
- Industry
- FGI Industrial Specialties
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- FGI Industrials
- ADXN Health Care
- Exchange
- FGI Nasdaq
- ADXN Nasdaq
- Market Cap
- FGI 5.5M
- ADXN 10.1M
- IPO Year
- FGI 2022
- ADXN N/A
- Fundamental
- Price
- FGI $0.65
- ADXN $8.83
- Analyst Decision
- FGI
- ADXN Strong Buy
- Analyst Count
- FGI 0
- ADXN 1
- Target Price
- FGI N/A
- ADXN $30.00
- AVG Volume (30 Days)
- FGI 163.3K
- ADXN 14.4K
- Earning Date
- FGI 08-06-2025
- ADXN 08-11-2025
- Dividend Yield
- FGI N/A
- ADXN N/A
- EPS Growth
- FGI N/A
- ADXN N/A
- EPS
- FGI N/A
- ADXN 0.10
- Revenue
- FGI $134,277,102.00
- ADXN $278,508.00
- Revenue This Year
- FGI $7.72
- ADXN $86.57
- Revenue Next Year
- FGI $6.94
- ADXN N/A
- P/E Ratio
- FGI N/A
- ADXN $0.78
- Revenue Growth
- FGI 11.13
- ADXN N/A
- 52 Week Low
- FGI $0.46
- ADXN $6.51
- 52 Week High
- FGI $1.20
- ADXN $13.27
- Technical
- Relative Strength Index (RSI)
- FGI 48.82
- ADXN 49.41
- Support Level
- FGI $0.64
- ADXN $8.78
- Resistance Level
- FGI $0.67
- ADXN $9.89
- Average True Range (ATR)
- FGI 0.09
- ADXN 0.67
- MACD
- FGI 0.00
- ADXN -0.03
- Stochastic Oscillator
- FGI 29.03
- ADXN 43.01
About FGI FGI Industries Ltd.
FGI Industries Ltd is a supplier of kitchen and bath products. The company is business to business supplier of bath and kitchen products to large retail, wholesale, commercial, and specialty channel customers around the globe. The company offers products that fall into four categories: Sanitaryware, Bath Furniture, Shower Systems and Other. The company generates the majority of its revenue from the sale of Sanitaryware products. Geographically, the company generates the majority of its revenue from the United States, followed by Canada and Europe.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.